CUOMO, ALESSANDRA
 Distribuzione geografica
Continente #
AS - Asia 1.644
EU - Europa 1.592
NA - Nord America 1.283
SA - Sud America 172
AF - Africa 66
OC - Oceania 3
Continente sconosciuto - Info sul continente non disponibili 1
Totale 4.761
Nazione #
US - Stati Uniti d'America 1.235
SG - Singapore 661
IT - Italia 655
RU - Federazione Russa 480
VN - Vietnam 384
CN - Cina 289
BR - Brasile 131
DE - Germania 121
HK - Hong Kong 101
FR - Francia 82
JP - Giappone 49
NL - Olanda 43
GB - Regno Unito 36
IN - India 34
FI - Finlandia 33
CA - Canada 29
PT - Portogallo 20
ES - Italia 18
AR - Argentina 17
ZA - Sudafrica 17
PH - Filippine 16
KR - Corea 15
PL - Polonia 15
CI - Costa d'Avorio 13
AT - Austria 12
BD - Bangladesh 12
LT - Lituania 12
IQ - Iraq 10
MX - Messico 10
UA - Ucraina 10
CO - Colombia 9
EG - Egitto 9
PK - Pakistan 9
TR - Turchia 9
BE - Belgio 8
IE - Irlanda 8
MA - Marocco 8
ID - Indonesia 7
KE - Kenya 6
SE - Svezia 6
TH - Thailandia 6
TW - Taiwan 6
VE - Venezuela 6
CZ - Repubblica Ceca 5
GE - Georgia 5
HR - Croazia 5
AE - Emirati Arabi Uniti 4
EC - Ecuador 4
JO - Giordania 4
MY - Malesia 4
RO - Romania 4
UZ - Uzbekistan 4
CH - Svizzera 3
RS - Serbia 3
TN - Tunisia 3
AU - Australia 2
AZ - Azerbaigian 2
BA - Bosnia-Erzegovina 2
BJ - Benin 2
DZ - Algeria 2
GR - Grecia 2
IL - Israele 2
JM - Giamaica 2
LV - Lettonia 2
NO - Norvegia 2
PA - Panama 2
SI - Slovenia 2
SK - Slovacchia (Repubblica Slovacca) 2
AM - Armenia 1
AO - Angola 1
CL - Cile 1
CR - Costa Rica 1
CY - Cipro 1
DM - Dominica 1
ET - Etiopia 1
GF - Guiana Francese 1
GY - Guiana 1
HN - Honduras 1
IR - Iran 1
KG - Kirghizistan 1
KW - Kuwait 1
MD - Moldavia 1
MM - Myanmar 1
MU - Mauritius 1
NG - Nigeria 1
NI - Nicaragua 1
NP - Nepal 1
NZ - Nuova Zelanda 1
OM - Oman 1
PY - Paraguay 1
SA - Arabia Saudita 1
SD - Sudan 1
SR - Suriname 1
SY - Repubblica araba siriana 1
VC - Saint Vincent e Grenadine 1
XK - ???statistics.table.value.countryCode.XK??? 1
YE - Yemen 1
YT - Mayotte 1
Totale 4.761
Città #
Singapore 325
San Jose 257
Ashburn 154
Moscow 128
Chandler 116
Ho Chi Minh City 104
Naples 102
Hong Kong 95
Hanoi 86
Hefei 84
Beijing 76
Santa Clara 47
Lauterbourg 40
Council Bluffs 35
Los Angeles 35
Munich 35
Milan 29
Rome 29
Tokyo 29
New York 22
Dallas 21
Frankfurt am Main 21
Millbury 21
Amsterdam 20
Buffalo 20
Palermo 20
Lawrence 19
The Dalles 18
Haiphong 16
Seattle 16
São Paulo 16
Bologna 15
Da Nang 15
Seoul 15
Napoli 14
Boston 12
Caserta 12
Des Moines 12
Helsinki 12
Toronto 12
Lappeenranta 11
London 11
Turin 11
Florence 10
Montijo 10
Orem 10
Redondo Beach 10
Bari 9
Nanjing 9
Sennori 9
Wilmington 9
Bogotá 8
Houston 8
Manfredonia 8
Biên Hòa 7
Brescia 7
Brooklyn 7
Chennai 7
Denver 7
Düsseldorf 7
Falkenstein 7
Hải Dương 7
Johannesburg 7
Kochi 7
Montreal 7
Nuremberg 7
Turku 7
Woodbridge 7
Atlanta 6
Catania 6
Foggia 6
Madrid 6
Nha Trang 6
Padova 6
Warsaw 6
Cagliari 5
Can Tho 5
Castelcovati 5
Chengdu 5
Chicago 5
Collecchio 5
Phoenix 5
Roubaix 5
Thái Bình 5
Vienna 5
Wroclaw 5
Belo Horizonte 4
Bến Tre 4
Cologne 4
Dong Ket 4
Dublin 4
Fairfield 4
Guangzhou 4
Karachi 4
Locorotondo 4
Mexico City 4
Nairobi 4
Oeiras 4
Olomouc 4
Ottawa 4
Totale 2.539
Nome #
Baseline cardio-oncologic risk assessment in breast cancer women and occurrence of cardiovascular events: The HFA/ICOS risk tool in real-world practice 742
Meccanismi molecolari della cardiotossicità indotta da antracicline e radioterapia 202
Evaluation of exercise capacity by means of cardiopulmonary exercise testing (CPET) in older adult cancer patients undergoing antineoplastic treatments 160
Impact of a cardio-oncology unit on prevention of cardiovascular events in cancer patients 152
Heart Failure and Cancer: Mechanisms of Old and New Cardiotoxic Drugs in Cancer Patients 149
Oxidative stress in anticancer therapies-related cardiac dysfunction 149
Prevention of cardiovascular complications in elderly cancer patients 149
New drugs, therapeutic strategies, and future direction for the treatment of Pulmonary Arterial Hypertension 144
New-Onset Cancer in the HF Population: Epidemiology, Pathophysiology, and Clinical Management 142
What is the cardiac impact of chemotherapy and subsequent radiotherapy in lymphoma patients 139
Cancer Risk in the Heart Failure Population: Epidemiology, Mechanisms, and Clinical Implications 138
Editorial: Myocardium regeneration and cardioprotection 136
How can we manage the cardiac toxicity of immune checkpoint inhibitors? 132
Low-intensity pulsed ultrasound (LIPUS) in heart failure with preserved ejection fraction (HFpEF): lupus in fabula? 130
Mildly Elevated Pulmonary Hypertension: Gray Zone or Already a Disease? 128
Pulmonary Hypertension Phenotypes in Systemic Sclerosis: The Right Diagnosis for the Right Treatment 127
Redox imbalances in ageing and metabolic alterations: Implications in cancer and cardiac diseases. An overview from the working group of cardiotoxicity and cardioprotection of the Italian society of cardiology (SIC) 127
Cardiovascular events and treatment of children with high risk medulloblastoma 126
Electrical Storm in Patients with Inappropriate Implantable Cardioverter-Defibrillator Therapy: Current Trends in Clinical Practice between Guidelines and Technology Progress 117
The broad spectrum of cardiotoxicities from immunotherapies 116
Cardiovascular Toxicity of Immune Checkpoint Inhibitors: Clinical Risk Factors 110
Predictors of sacubitril/valsartan high dose tolerability in a real world population with HFrEF 110
Metabolomic perspectives in antiblastic cardiotoxicity and cardioprotection 108
Commentary on “Functional Improvement After Outpatient Cardiac Rehabilitation in Acute Coronary Syndrome Patients is not Related to Improvement in Left Ventricular Ejection Fraction” 108
Causes and outcomes of {ICU} hospitalisations in patients with pulmonary arterial hypertension 103
Cardio-Oncology Challenges in Elderly Patients 102
Prevention of cancer-therapy-related heart failure 101
Pembrolizumab associated hypereosinophilia in locally advanced triple-negative breast cancer 97
Inflammatory Mechanisms in the Pathogenesis of Pulmonary Arterial Hypertension: Recent Advances 87
Risk Stratification of Patients with Pulmonary Arterial Hypertension: The Role of Echocardiography 80
Is it time to update our defibrillation strategies for refractory ventricular fibrillation? 74
Inflammation at the crossroad between cancer and heart failure 64
Virtual reality solution to promote adapted physical activity in older adults: outcomes from VR2Care project exploratory study 51
Digital interventions addressing the unmet needs of older adults with multimorbidity: a mixed-methods persona design approach 48
TAPSE/sPAP Ratio to Improve Risk Assessment in Pulmonary Arterial Hypertension 44
Exploring motivational readiness for adapted physical activity in older adults with chronic illness: patterns of self-care behaviors, engagement, and psychological distress 39
Nonpharmacological management of pulmonary arterial hypertension 34
The Activin Pathway in Chronic Thromboembolic Pulmonary Hypertension: A Potential Biomarker for Residual Pulmonary Hypertension After Endarterectomy 27
ERS Congress 2024: highlights from the Pulmonary Vascular Diseases Assembly 16
Exploring the Endothelin-1 pathway in chronic thromboembolic pulmonary hypertension microvasculopathy 15
Placental growth factor modulates endothelial NO production and exacerbates experimental hepatopulmonary syndrome 15
Totale 4.838
Categoria #
all - tutte 14.372
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 14.372


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2020/20215 0 0 0 0 0 0 0 0 0 0 0 5
2021/2022144 6 0 0 8 2 5 11 8 3 16 41 44
2022/2023597 21 34 41 46 59 43 45 86 124 53 25 20
2023/2024340 19 20 33 39 22 52 20 42 17 20 32 24
2024/20251.216 49 44 6 28 28 110 109 100 73 113 429 127
2025/20262.399 213 173 277 187 412 85 350 134 280 193 81 14
Totale 4.838